Journal list menu
Export Citations
Download PDFs
Cover Image
Issue Information
Hepatology Highlights
Editorials
no
New Glance at the Role of TM6SF2 in Lipid Metabolism and Liver Cancer
- Pages: 1141-1144
- First Published: 07 April 2021
Original Articles
Viral Hepatitis
Open Access
oa
Pathogenesis, MicroRNA-122 Gene-Regulation, and Protective Immune Responses After Acute Equine Hepacivirus Infection
- Pages: 1148-1163
- First Published: 13 March 2021
Open Access
oa
Hematological and Genetic Markers in the Rational Approach to Patients With HCV Sustained Virological Response With or Without Persisting Cryoglobulinemic Vasculitis
- Pages: 1164-1173
- First Published: 15 March 2021
no
A Prospective Study Evaluating Changes in Histology, Clinical and Virologic Outcomes in HBV-HIV Co-infected Adults in North America
- Pages: 1174-1189
- First Published: 20 March 2021
no
Risk of HCC With Hepatitis B Viremia Among HIV/HBV-Coinfected Persons in North America
- Pages: 1190-1202
- First Published: 29 March 2021
Steatohepatitis/Metabolic Liver Disease
no
Liver-Specific Deletion of Mouse Tm6sf2 Promotes Steatosis, Fibrosis, and Hepatocellular Cancer
- Pages: 1203-1219
- First Published: 27 February 2021
Open Access
oa
Glycemic Control Predicts Severity of Hepatocyte Ballooning and Hepatic Fibrosis in Nonalcoholic Fatty Liver Disease
- Pages: 1220-1233
- First Published: 16 March 2021
no
Stress-Responsive Gene FK506-Binding Protein 51 Mediates Alcohol-Induced Liver Injury Through the Hippo Pathway and Chemokine (C-X-C Motif) Ligand 1 Signaling
- Pages: 1234-1250
- First Published: 12 March 2021
no
TNF-α-Induce Protein 8–Like 1 Inhibits Hepatic Steatosis, Inflammation, and Fibrosis by Suppressing Polyubiquitination of Apoptosis Signal–Regulating Kinase 1
- Pages: 1251-1270
- First Published: 13 March 2021
no
Steatotic Hepatocytes Release Mature VLDL Through Methionine and Tyrosine Metabolism in a Keap1-Nrf2–Dependent Manner
- Pages: 1271-1286
- First Published: 16 March 2021
no
Increased Adipose Tissue Fibrogenesis, Not Impaired Expandability, Is Associated With Nonalcoholic Fatty Liver Disease
- Pages: 1287-1299
- First Published: 20 March 2021
no
Tumor Necrosis Factor α–Induced Protein 8–Like 2 Alleviates Nonalcoholic Fatty Liver Disease Through Suppressing Transforming Growth Factor Beta–Activated Kinase 1 Activation
- Pages: 1300-1318
- First Published: 26 March 2021
no
Hepatocyte SH3RF2 Deficiency Is a Key Aggravator for NAFLD
- Pages: 1319-1338
- First Published: 24 April 2021
Hepatobiliary Malignancies
no
Insufficient Radiofrequency Ablation Promotes Hepatocellular Carcinoma Metastasis Through N6-Methyladenosine mRNA Methylation-Dependent Mechanism
- Pages: 1339-1356
- First Published: 26 February 2021
Open Access
oa
The Co-mutational Spectrum Determines the Therapeutic Response in Murine FGFR2 Fusion-Driven Cholangiocarcinoma
- Pages: 1357-1370
- First Published: 11 March 2021
no
A Transcriptomic Signature for Risk-Stratification and Recurrence Prediction in Intrahepatic Cholangiocarcinoma
- Pages: 1371-1383
- First Published: 16 March 2021
no
State-Level HCC Incidence and Association With Obesity and Physical Activity in the United States
- Pages: 1384-1394
- First Published: 17 March 2021
Open Access
oa
Analysis and Validation of Human Targets and Treatments Using a Hepatocellular Carcinoma–Immune Humanized Mouse Model
- Pages: 1395-1410
- First Published: 18 March 2021
no
Sulfatase 2 (SULF2) Monoclonal Antibody 5D5 Suppresses Human Cholangiocarcinoma Xenograft Growth Through Regulation of a SULF2–Platelet-Derived Growth Factor Receptor Beta–Yes-Associated Protein Signaling Axis
- Pages: 1411-1428
- First Published: 18 March 2021
no
Genetic Determinants of Outcome in Intrahepatic Cholangiocarcinoma
- Pages: 1429-1444
- First Published: 25 March 2021
no
A Mouse Model of Cholangiocarcinoma Uncovers a Role for Tensin-4 in Tumor Progression
- Pages: 1445-1460
- First Published: 26 March 2021
Open Access
oa
Loss-of-Function Genetic Screening Identifies Aldolase A as an Essential Driver for Liver Cancer Cell Growth Under Hypoxia
- Pages: 1461-1479
- First Published: 04 April 2021
no
HBV/Pregenomic RNA Increases the Stemness and Promotes the Development of HBV-Related HCC Through Reciprocal Regulation With Insulin-Like Growth Factor 2 mRNA-Binding Protein 3
- Pages: 1480-1495
- First Published: 07 April 2021
Autoimmune, Cholestatic and Biliary Disease
Open Access
oa
Accuracy of Transient Elastography in Assessing Fibrosis at Diagnosis in Naïve Patients With Primary Biliary Cholangitis: A Dual Cut-Off Approach
- Pages: 1496-1508
- First Published: 16 March 2021
Liver Failure/Cirrhosis/ Portal Hypertension
no
Financial Hardship From Medical Bills Among Adults With Chronic Liver Diseases: National Estimates From the United States
- Pages: 1509-1522
- First Published: 26 March 2021
no
Black Patients Have Unequal Access to Listing for Liver Transplantation in the United States
- Pages: 1523-1532
- First Published: 29 March 2021
Open Access
oa
The Addition of C-Reactive Protein and von Willebrand Factor to Model for End-Stage Liver Disease-Sodium Improves Prediction of Waitlist Mortality
- Pages: 1533-1545
- First Published: 31 March 2021
Liver Injury/ Regeneration
no
In Utero Exposure to Mercury Is Associated With Increased Susceptibility to Liver Injury and Inflammation in Childhood
- Pages: 1546-1559
- First Published: 17 March 2021
no
CD47-Mediated Hedgehog/SMO/GLI1 Signaling Promotes Mesenchymal Stem Cell Immunomodulation in Mouse Liver Inflammation
- Pages: 1560-1577
- First Published: 25 March 2021
no
Perivenous Stellate Cells Are the Main Source of Myofibroblasts and Cancer-Associated Fibroblasts Formed After Chronic Liver Injuries
- Pages: 1578-1594
- First Published: 05 April 2021
Liver Biology/Pathobiology
no
Proteomic Profiling of Hepatocellular Adenomas Paves the Way to Diagnostic and Prognostic Approaches
- Pages: 1595-1610
- First Published: 23 March 2021
AASLD Guidance
Free Access
free
Malnutrition, Frailty, and Sarcopenia in Patients With Cirrhosis: 2021 Practice Guidance by the American Association for the Study of Liver Diseases
- Pages: 1611-1644
- First Published: 07 July 2021
Special Article
no
Responsible Inclusion of Pregnant Individuals in Eradicating HCV
- Pages: 1645-1651
- First Published: 20 March 2021
Concise Review
no
Long Noncoding RNA H19: A Key Player in Liver Diseases
- Pages: 1652-1659
- First Published: 25 February 2021
Reviews
Open Access
oa
The Use of Rifaximin in Patients With Cirrhosis
- Pages: 1660-1673
- First Published: 09 January 2021
no
Pulmonary Abnormalities in Liver Disease: Relevance to Transplantation and Outcome
- Pages: 1674-1686
- First Published: 26 February 2021
Hepatology Elsewhere
no
A Spotlight on the Drivers of Inflammation in Acute Liver Failure
- Pages: 1687-1689
- First Published: 19 March 2021
Open Access
oa
Sinusoidal Endothelial Cells as Orchestrators of the Gut Liver Immune Axis
- Pages: 1690-1691
- First Published: 30 April 2021
no
Hepatocytes Induce Change in Their Neighbors by YAP-ing at Them
- Pages: 1692-1694
- First Published: 30 April 2021
Clinical Observations in Hepatology
no
Primary Hepatic Squamous Cell Carcinoma With High Microsatellite Instability Shows Good Response to Programmed Cell Death 1 Inhibitor as Adjuvant Therapy
- Pages: 1695-1697
- First Published: 05 February 2021
no
Recurrent Nodular Regenerative Hyperplasia Following Liver Transplantation in Common Variable Immunodeficiency
- Pages: 1698-1701
- First Published: 27 February 2021
no
Mevalonic Aciduria Associated With Intrahepatic Bile Duct Paucity
- Pages: 1702-1704
- First Published: 27 February 2021
no
Paraneoplastic Polyarthritis in Hepatocellular Carcinoma Treated With Lenvatinib
- Pages: 1705-1707
- First Published: 11 March 2021
Correspondence
no
Letter to the Editor: Evaluating Liver Function in Patients With Cirrhosis
- Page: 1708
- First Published: 13 November 2020
no
Letter to the Editor: Examining HBV-RNA Kinetics During NA Treatment—Are NAs Multifunctional Antiviral Agents?
- Pages: 1708-1709
- First Published: 13 November 2020
no
Letter to the Editor: Comment on “The Application of Artificial Intelligence for the Diagnosis and Treatment of Liver Diseases”
- Page: 1710
- First Published: 13 November 2020
no
Letter to the Editor: Immune-Mobilizing Monoclonal T-Cell Receptors: A Novel Addition in the HBV Armamentarium
- Pages: 1710-1711
- First Published: 21 November 2020
Open Access
oa
Letter to the Editor: Liver Cell Models for Premature Termination Codon Readthrough Analyses
- Pages: 1711-1712
- First Published: 13 December 2020
no
Letter to the Editor: H19 Promotes HCC Bone Metastasis by Reducing Osteoprotegerin Expression in a PPP1CA/p38MAPK-Dependent Manner and Sponging miR-200b-3p
- Page: 1713
- First Published: 18 January 2021
no
Letter to the Editor: Hepatocellular Carcinoma Surveillance in Cirrhosis Patients: Is the Real-World Situation Even Worse Than Reported?
- Pages: 1714-1715
- First Published: 22 February 2021
no
Letter to the Editor: Oral Vancomycin Versus No Therapy for Pediatric Primary Sclerosing Cholangitis
- Pages: 1716-1717
- First Published: 26 February 2021
no
Letter to the Editor: Restructuring the Gut Microbiota of Patients with Cirrhosis After HCV Eradication: A Matter of Time?
- Page: 1718
- First Published: 05 March 2021
no
Letter to the Editor: Recognizing Significant Role of Neoadjuvant Radiotherapy for HCC With Vascular Invasion
- Page: 1719
- First Published: 05 March 2021
no
Letter to the Editor: The Differences Between the Reverse Transcriptional Efficiency of HBV Pregenomic RNA and Transcriptional Efficiency of HBV Covalently Closed Circular DNA
- Pages: 1720-1721
- First Published: 04 March 2021
no
Letter to the Editor: Balloon-Occluded Retrograde Transvenous Obliteration for Prevention of Gastric Variceal Rebleeding: A Paradigm Shift?
- Pages: 1721-1722
- First Published: 20 March 2021
Obituary
Free Access
free
Obituary for Roberto J. Groszmann—The Father of Portal Hypertension
- Pages: 1724-1726
- First Published: 09 June 2021